Ind-Swift [INDSWFTLAB] vs Innova Captab [INNOVACAP] Detailed Stock Comparison

Ind-Swift Laboratories Ltd.

NSE
Loading...

Innova Captab Ltd.

NSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Ind-Swift Laboratories Ltd. wins in 13 metrics, Innova Captab Ltd. wins in 5 metrics, with 0 ties. Ind-Swift Laboratories Ltd. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Ind-Swift Laboratories Ltd. Innova Captab Ltd. Better
P/E Ratio (TTM) 4.00 31.20 Ind-Swift Laboratories Ltd.
Price-to-Book Ratio 0.84 4.05 Ind-Swift Laboratories Ltd.
Debt-to-Equity Ratio 1.69 32.95 Ind-Swift Laboratories Ltd.
PEG Ratio 0.05 1.33 Ind-Swift Laboratories Ltd.
EV/EBITDA -14.12 20.49 Innova Captab Ltd.
Profit Margin (TTM) 41.86% 8.85% Ind-Swift Laboratories Ltd.
Operating Margin (TTM) -3.09% 12.88% Innova Captab Ltd.
EBITDA Margin (TTM) N/A 12.88% N/A
Return on Equity 21.35% 13.37% Ind-Swift Laboratories Ltd.
Return on Assets (TTM) 17.41% 8.12% Ind-Swift Laboratories Ltd.
Free Cash Flow (TTM) $-898.80M $-1.09B Ind-Swift Laboratories Ltd.
Dividend Yield N/A 0.30% N/A
1-Year Return 87.37% -3.19% Ind-Swift Laboratories Ltd.
Price-to-Sales Ratio (TTM) 2.02 2.76 Ind-Swift Laboratories Ltd.
Enterprise Value $7.27B $43.41B Innova Captab Ltd.
EV/Revenue Ratio 1.23 2.90 Ind-Swift Laboratories Ltd.
Gross Profit Margin (TTM) 53.44% 35.19% Ind-Swift Laboratories Ltd.
Revenue per Share (TTM) $76 $262 Innova Captab Ltd.
Earnings per Share (Diluted) $34.48 $23.16 Ind-Swift Laboratories Ltd.
Beta (Stock Volatility) 0.67 -0.33 Innova Captab Ltd.

Ind-Swift Laboratories Ltd. vs Innova Captab Ltd. Stock Performance Analysis

Loading Price Chart...

INDSWFTLAB
INNOVACAP

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Ind-Swift Laboratories Ltd.-3.08%19.04%19.20%18.12%69.63%79.14%
Innova Captab Ltd.-0.63%2.24%2.13%29.82%21.15%16.79%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Ind-Swift Laboratories Ltd.87.37%115.45%76.77%265.65%53.11%93.40%
Innova Captab Ltd.-3.19%57.07%57.07%57.07%57.07%57.07%

Performance & Financial Health Analysis: Ind-Swift Laboratories Ltd. vs Innova Captab Ltd.

MetricINDSWFTLABINNOVACAP
Market Information
Market Cap i₹11.98B₹41.43B
Market Cap CategorySmall capSmall cap
10 Day Avg. Volume i2,938,854578,151
90 Day Avg. Volume i1,379,551217,693
Last Close₹157.11₹857.00
52 Week Range₹81.90 - ₹173.25₹622.00 - ₹1,020.70
% from 52W High-9.32%-16.04%
All-Time High₹296.50 (Dec 20, 2004)₹1,260.00 (Jan 06, 2025)
% from All-Time High-47.01%-31.98%
Growth Metrics
Quarterly Revenue Growth16.41%0.42%
Quarterly Earnings Growth1,537.44%0.23%
Financial Health
Profit Margin (TTM) i0.42%0.09%
Operating Margin (TTM) i-0.03%0.13%
Return on Equity (TTM) i0.21%0.13%
Debt to Equity (MRQ) i1.6932.95
Cash & Liquidity
Book Value per Share (MRQ)₹163.64₹178.28
Cash per Share (MRQ)₹51.43₹10.22
Operating Cash Flow (TTM) i₹-213,518,000₹282.88M
Levered Free Cash Flow (TTM) i₹2.50B₹1.28B
Dividends
Last 12-Month Dividend Yield iN/A0.30%
Last 12-Month Dividend i₹0.00₹2.00

Valuation & Enterprise Metrics Analysis: Ind-Swift Laboratories Ltd. vs Innova Captab Ltd.

MetricINDSWFTLAB (Apr 24, 2026)INNOVACAP (Apr 24, 2026)
Price Ratios
P/E Ratio (TTM) i4.0031.20
Forward P/E iN/A21.90
PEG Ratio i0.051.33
Price to Sales (TTM) i2.022.76
Price to Book (MRQ) i0.844.05
Market Capitalization
Market Capitalization i₹11.98B₹41.43B
Enterprise Value i₹7.27B₹43.41B
Enterprise Value Metrics
Enterprise to Revenue i1.232.90
Enterprise to EBITDA i-14.1220.49
Risk & Other Metrics
Beta i0.67-0.33
Book Value per Share (MRQ) i₹163.64₹178.28

Financial Statements Comparison: Ind-Swift Laboratories Ltd. vs Innova Captab Ltd.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricINDSWFTLAB (2025)INNOVACAP (2025)
Revenue/Sales i5.62B12.34B
Cost of Goods Sold i3.38B8.38B
COGS % of Revenue i60.2%67.9%
Gross Profit i2.23B3.96B
Gross Margin i39.8%32.1%
Research & Development iN/AN/A
Operating Income (EBIT) i-416.41M1.65B
Operating Margin i-7.4%13.4%
EBITDA i317.34M2.00B
EBITDA Margin i5.6%16.2%
Pre-Tax Income i2.58B1.71B
Pre-Tax Income % of Revenue i45.9%13.9%
Income Tax i72.70M427.58M
Income Tax % of Revenue i1.3%3.5%
Net Income (Profit) i2.50B1.28B
Profit Margin i44.6%10.4%

Balance Sheet & Liquidity Metrics

MetricINDSWFTLAB (2025)INNOVACAP (2025)
Cash & Equivalents i4.12B155.19M
Total Current Assets i8.65B7.03B
Total Current Assets % of Revenue i154.1%57.0%
Total Current Liabilities i2.21B3.53B
Total Current Liabilities % of Revenue i39.3%28.6%
Long-Term Debt i259.35M2.45B
Long-Term Debt % of Revenue i4.6%19.8%
Total Shareholders Equity i11.73B9.59B
Retained Earnings i-1.38B4.53B
Retained Earnings % of Revenue i-24.5%36.7%
Property, Plant & Equipment i270.23M442.93M

Cash Flow Statement Comparison

MetricINDSWFTLAB (2025)INNOVACAP (2025)
Operating Cash Flow i-213.52M282.88M
Operating Cash Flow % of Revenue i-3.8%2.3%
Capital Expenditures i-258.10M-1.72B
Free Cash Flow i-898.80M-1.09B
FCF Margin i-16.0%-8.8%
Debt Repayment i-66.04M-114.03M
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricINDSWFTLABINNOVACAP
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Shares Outstanding i86.84M57.22M
Float Shares i25.94M15.91M
% Held by Insiders i66.37%72.19%
% Held by Institutions i4.62%19.22%
% Held by Public i29.01%8.59%

Dividend Analysis & Yield Comparison: Ind-Swift Laboratories Ltd. vs Innova Captab Ltd.

MetricINDSWFTLABINNOVACAP
Last 12-Month Dividend i₹0.00₹2.00
Last 12-Month Dividend Yield iN/A0.30%
3-Year Avg Annual Dividend i₹0.00₹0.67
3-Year Avg Dividend Yield iN/A0.30%
3-Year Total Dividends i₹0.00₹2.00
Ex-Dividend DateN/AJan 30, 2026